Clobetasol

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28ClFO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ADN79D536H, chemically known as 21-chloro-9-fluoro-11b,17-dihydroxy-16a-methylpregna-1,4-diene-3,20-dione but generally known as clobetasol, which bears US NIH Compound Identifier 32797. European Medicines Agency schedules Clobetasol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06678MIG. World Health Organization schedules clobetasol in its Anatomical Therapeutic Chemical (ATC) Classification. CLOBETASOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clobetasol under HS 29372200 and SITC 54153. As of Q4 2014, CLOBETASOL remains the US FDA Preferred Term for this commodity. Clobetasol bears US NLM identifiers UMLS ID C0008992 and NCI Concept Code C65339. SMILES: CLCC(=O)C1(O)C2(C(C3C(F)(C(O)C2)C2(C(=CC(=O)C=C2)CC3)C)CC1C)C.